Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Naltrexone Treatment in Pathologic Gambling Disorder

NCT00053677 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00053677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00053677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Naltrexone Treatment in Pathologic Gambling Disorder
Lead sponsor
University of Chicago
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2002
Completion date
November 30, 2005
Enrollment
83 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gambling